Stockscreener 앱 받기
3.47
2.66%
0.09
시간 외 거래:
3.46
-0.01
-0.29%
Checkpoint Therapeutics Inc 주식(CKPT)의 최신 뉴스
Valora Therapeutics Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint Platform - Business Wire
Investigation announced for Long-Term Investors in shares - openPR
Checkpoint Therapeutics’ (CKPT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Research Analysts Offer Predictions for CKPT FY2024 Earnings - MarketBeat
Checkpoint Therapeutics Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.29 loss in 3Q 2023) - Yahoo Finance
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Checkpoint Therapeutics Inc - GuruFocus.com
Checkpoint Therapeutics: Preparing For Cosibelimab’s Upcoming PDUFA Date (NASDAQ:CKPT) - Seeking Alpha
Caterpillar Inc (CAT-N) QuotePress Release - The Globe and Mail
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics Sets FDA Review Date, Secures $9.2M Funding Boost Amid Q3 Loss | FBIO Stock News - StockTitan
S&P Midcap Micro (OMZ23) Quote - The Globe and Mail
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
Vimeo Inc (VMEO-Q) QuotePress Release - The Globe and Mail
What Analysts Were Expecting After Checkpoint Therapeutics Inc (NASDAQ: CKPT) rose 2.03% - Stocks Register
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus.com
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Short Interest Update - MarketBeat
Kadant Inc (KAI-N) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics stock hits 52-week high at $3.62 By Investing.com - Investing.com Australia
Checkpoint Therapeutics stock hits 52-week high at $3.62 - Investing.com
Toyota Motor Corp Ltd Ord ADR (TM-N) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics Inc (CKPT) Is A Good Stock To Invest In - Stocks Register
Lucid Group Inc (LCID-Q) QuotePress Release - The Globe and Mail
Boston-area biotechs await drug approval decisions in coming months - The Business Journals
Do investors need to be concerned about Checkpoint Therapeutics Inc (CKPT)? - US Post News
Checkpoint Therapeutics Inc [CKPT] CEO, President and Director makes an insider sale of 24,610 shares worth $50450.0. – Knox Daily - Knox Daily
Checkpoint Therapeutics Inc (CKPT)’s results reveal risk - US Post News
Janux Therapeutics Inc [JANX] Stock sold by Insider Avalon Ventures XI, L.P. for $5.18 million - Knox Daily
Understanding the Risks of Investing in Harrow Inc (HROW) - Knox Daily
Checkpoint Therapeutics Inc [CKPT] stock was sold by Oliviero James F III at the price of US$50450.0 - Knox Daily
Recent Insider Activity Suggests Potential Gains for Corcept Therapeutics Inc (CORT) - Knox Daily
Acadia Pharmaceuticals Inc (ACAD) Becoming More Attractive for Investors - Knox Daily
Gain Therapeutics Inc [GANX] Investment Guide: What You Need to Know - Knox Daily
Viridian Therapeutics Inc (VRDN) receives a Buy rating from Needham - Knox Daily
Liberty Energy Inc [LBRT] Investment Appeal on the Rise - Knox Daily
Surf Air Mobility Inc [SRFM] Investment Guide: What You Need to Know - Knox Daily
Recent Insider Activity Could Benefit Opendoor Technologies Inc (OPEN) - Knox Daily
Howmet Aerospace Inc [HWM] Insider Activity: An Update for Investors - Knox Daily
Zentalis Pharmaceuticals Inc [ZNTL] Insider Vultaggio Vincent sells 1,603 Shares – Company Insider Activity - Knox Daily
Checking in on TG Therapeutics Inc (TGTX) after recent insiders movement - Knox Daily
Investing in SS&C Technologies Holdings Inc (SSNC): What You Must Know - Knox Daily
KBR Inc [KBR] stock was sold by Ibrahim Jalal at the price of US$2.33 million - Knox Daily
Confluent Inc (CFLT) receives a Neutral rating from Robert W. Baird - Knox Daily
Alnylam Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
The Attractiveness of Investing In Cerence Inc (CRNC) is Growing - Knox Daily
PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily
KPTI’s latest rating updates from top analysts. - Knox Daily
Enphase Energy Inc (ENPH) receives a Mkt perform rating from William Blair - Knox Daily
Consol Energy Inc (CEIX) Becoming More Attractive for Investors - Knox Daily
Investing in Myriad Genetics, Inc. (MYGN): What You Must Know - Knox Daily
Rocket Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Citigroup’s latest rating for CPRX stock - Knox Daily
Goldman analysts downgrades a Neutral rating for Intellia Therapeutics Inc (NTLA) - Knox Daily
Examining the Potential Price Growth of Squarespace Inc (SQSP) - Knox Daily
An Analysis of Altimmune Inc (ALT)’s Potential Price Growth - Knox Daily
Zumiez Inc (ZUMZ) gets rating Downgrade from William Blair - Knox Daily
Potential Price Increase for Travere Therapeutics Inc (TVTX) After Recent Insider Activity - Knox Daily
N-able Inc (NABL) Becoming More Attractive for Investors - Knox Daily
Mersana Therapeutics Inc [MRSN] Investment Appeal on the Rise - Knox Daily
Raymond James gives a Mkt perform recommendation for ACV Auctions Inc (ACVA) - Knox Daily
SpringWorks Therapeutics Inc (SWTX) receives a Buy rating from Guggenheim - Knox Daily
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
The Potential Rise in the Price of Denali Therapeutics Inc (DNLI) following insiders activity - Knox Daily
Is Checkpoint Therapeutics Inc (NASDAQ: CKPT) Doomed To Fail? - Stocks Register
Investing in Viavi Solutions Inc (VIAV) Is Getting More Attractive - Knox Daily
0.93%
3.55%
자본화:
|
볼륨(24시간):